Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:1519  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 

    Article Cited by others


Fundamentals of vaccine immunology

Clem Angela S

Year : 2011| Volume: 3| Issue : 1 | Page no: 73-78

   This article has been cited by
1 Mechanisms underpinning poor antibody responses to vaccines in ageing
Jia Le Lee, Michelle A Linterman
Immunology Letters. 2022; 241: 1
[Pubmed]  [Google Scholar] [DOI]
2 T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
Elahe Aleebrahim-Dehkordi, Bahareh Molavi, Melika Mokhtari, Niloofar Deravi, Mobina Fathi, Tara Fazel, Mehdi Mohebalizadeh, Pooneh Koochaki, Parnian Shobeiri, Ali Hasanpour-Dehkordi
Transplant Immunology. 2022; 70: 101495
[Pubmed]  [Google Scholar] [DOI]
3 Non-specific effects of veterinary vaccines: a systematic review
Sintayehu M. Arega, Darryn L. Knobel, Felix N. Toka, Anne Conan
Vaccine. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Vaccination Update for Nurse Practitioners Caring for Adults
Patrick C. Crane
Advances in Family Practice Nursing. 2021; 3: 15
[Pubmed]  [Google Scholar] [DOI]
5 B cell therapy and the use of RNA-based COVID-19 vaccines
Anastasia Vishnevetsky, Chris Hawkes, Jeannette Lechner-Scott, Gavin Giovannoni, Michael Levy, Daniela Pohl
Multiple Sclerosis and Related Disorders. 2021; 49: 102887
[Pubmed]  [Google Scholar] [DOI]
6 Brain Tumor Vaccines
Justin Lee, Benjamin R. Uy, Linda M. Liau
Neurosurgery Clinics of North America. 2021; 32(2): 225
[Pubmed]  [Google Scholar] [DOI]
7 Positive affect and peripheral inflammatory markers among adults: A narrative review
Dusti R. Jones, Jennifer E. Graham-Engeland
Psychoneuroendocrinology. 2021; 123: 104892
[Pubmed]  [Google Scholar] [DOI]
8 Early-life exposure to widespread environmental toxicants and children's health risks: A focus on the post-vaccination antibody potency or immunoglobulin levels
Zhijun Zeng, Sieglind Ngai, Qihua Wang, Wanting Liang, Xia Huo
Science of The Total Environment. 2021; 781: 146714
[Pubmed]  [Google Scholar] [DOI]
9 Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, Abtie Abebaw, Melese Getachew, Tengchuan Jin
Seminars in Immunology. 2021; : 101533
[Pubmed]  [Google Scholar] [DOI]
10 Designing a multi-epitope vaccine against Mycobacteroides abscessus by pangenome-reverse vaccinology
Hamza Arshad Dar, Saba Ismail, Yasir Waheed, Sajjad Ahmad, Zubia Jamil, Hafsa Aziz, Helal F. Hetta, Khalid Muhammad
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
11 A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2
Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble, Sathiah Thennarasu
RSC Advances. 2021; 11(33): 20006
[Pubmed]  [Google Scholar] [DOI]
12 Zebrafish Embryos Immune System induction with BSA as an initial Screening model for Covid-19 Treatment
Dita Arya Widatama, Bambang Retnoaji
IOP Conference Series: Earth and Environmental Science. 2021; 755(1): 012012
[Pubmed]  [Google Scholar] [DOI]
13 Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies?
Melanie Malave Sanchez, Paul Saleeb, Shyam Kottilil, Poonam Mathur
Open Forum Infectious Diseases. 2021; 8(8)
[Pubmed]  [Google Scholar] [DOI]
14 Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience
Helena Wichova, Mia E. Miller, M. Jennifer Derebery
Otology & Neurotology. 2021; 42(9): e1213
[Pubmed]  [Google Scholar] [DOI]
15 Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future
Ester Calvo Fernández, Lucie Y. Zhu
British Journal of Clinical Pharmacology. 2021; 87(9): 3408
[Pubmed]  [Google Scholar] [DOI]
16 A guide to investigating immune responses elicited by whole-sporozoite pre-erythrocytic vaccines against malaria
Diana Moita, Helena Nunes-Cabaço, António M. Mendes, Miguel Prudêncio
The FEBS Journal. 2021;
[Pubmed]  [Google Scholar] [DOI]
17 Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
Hannah Kelly, Brent Sokola, Hesham Abboud
Journal of Neuroimmunology. 2021; 356: 577599
[Pubmed]  [Google Scholar] [DOI]
18 Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view
Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh, Krishna Das Saha
Life Sciences. 2021; 278: 119580
[Pubmed]  [Google Scholar] [DOI]
19 Biomaterials and nanomaterials for sustained release vaccine delivery
Michael A. Luzuriaga, Arezoo Shahrivarkevishahi, Fabian C. Herbert, Yalini H. Wijesundara, Jeremiah J. Gassensmith
WIREs Nanomedicine and Nanobiotechnology. 2021; 13(6)
[Pubmed]  [Google Scholar] [DOI]
20 Enhancement of immunopotentiation using tetanus toxoid-based nanoparticulate dissolvable microneedles
Mansi Waghchaure, Sharayu Govardhane, Pravin Shende
Biomedical Microdevices. 2021; 23(3)
[Pubmed]  [Google Scholar] [DOI]
21 Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome
Advances in Therapy. 2021; 38(7): 3550
[Pubmed]  [Google Scholar] [DOI]
22 Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar, Lalit K. Vora, Tapan A. Patel, Maxim D. Oleynikov, Dhruvkumar Soni, Pravin Yeapuri, Insiya Mukadam, Rajashree Chakraborty, Caroline G. Saksena, Jonathan Herskovitz, Mahmudul Hasan, David Oupicky, Suvarthi Das, Ryan F. Donnelly, Kenneth S. Hettie, Linda Chang, Howard E. Gendelman, Bhavesh D. Kevadiya
Advanced Drug Delivery Reviews. 2021; 171: 215
[Pubmed]  [Google Scholar] [DOI]
23 Vaccine delivery systems toward lymph nodes
Yingyue Ding, Zhaoting Li, Ana Jaklenec, Quanyin Hu
Advanced Drug Delivery Reviews. 2021; : 113914
[Pubmed]  [Google Scholar] [DOI]
24 Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
Charles Yap, Abulhassan Ali, Amogh Prabhakar, Akul Prabhakar, Aman Pal, Ying Yi Lim, Pramath Kakodkar
Therapeutic Advances in Vaccines and Immunotherapy. 2021; 9: 2515135521
[Pubmed]  [Google Scholar] [DOI]
25 Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009–2016)
Aidan M. Nikiforuk, Mohammad Ehsanul Karim, David M. Patrick, Agatha N. Jassem
BMC Public Health. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
26 Knowledge and Attitudes of Young Adults Towards Donation of COVID-19 Convalescent Plasma and Its Therapeutic Properties
Lidia Perenc, Ryszard Peczkowski
Journal of Blood Medicine. 2021; Volume 12: 709
[Pubmed]  [Google Scholar] [DOI]
27 The PentaFOLD 3.0 Algorithm for the Selection of Stable Elements of Secondary Structure to be Included in Vaccine Peptides
Vladislav V. Khrustalev
Protein & Peptide Letters. 2021; 28(5): 573
[Pubmed]  [Google Scholar] [DOI]
28 An Updated Overview of Herpes Simplex Virus-1 Infection: Insights from Origin to Mitigation Measures
Abu Tayab Moin, Mohammad Al-baruni Chowdhury, Sumaiya Hafiz Riana, Md. Asad Ullah, Yusha Araf, Bishajit Sarkar, Abdullah Mohammad Shohael
Electronic Journal of General Medicine. 2021; 18(4): em299
[Pubmed]  [Google Scholar] [DOI]
Ankara Universitesi Eczacilik Fakultesi Dergisi. 2021; : 109
[Pubmed]  [Google Scholar] [DOI]
30 Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Alexander J. Stephens, Nicola A. Burgess-Brown, Shisong Jiang
Frontiers in Immunology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
31 Hijacking of the Host’s Immune Surveillance Radars by Burkholderia pseudomallei
Vanitha Mariappan, Kumutha Malar Vellasamy, Muttiah Barathan, A. S. Smiline Girija, Esaki M. Shankar, Jamuna Vadivelu
Frontiers in Immunology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
32 Recent Development of Ruminant Vaccine Against Viral Diseases
Sk Mohiuddin Choudhury, XuSheng Ma, Wen Dang, YuanYuan Li, HaiXue Zheng
Frontiers in Veterinary Science. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
33 COVID-19 Vaccines: Current Conditions and Future Prospects
Tarek Zieneldien, Janice Kim, Jessica Cao, Chuanhai Cao
Biology. 2021; 10(10): 960
[Pubmed]  [Google Scholar] [DOI]
34 Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth
Courtney T. Stump, Gregory Ho, Chenkai Mao, Frank A. Veliz, Veronique Beiss, Jennifer Fields, Nicole F. Steinmetz, Steven Fiering
Cancers. 2021; 13(4): 627
[Pubmed]  [Google Scholar] [DOI]
35 What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus?
Richard G. Wamai, Jason L. Hirsch, Wim Van Damme, David Alnwick, Robert C. Bailey, Stephen Hodgins, Uzma Alam, Mamka Anyona
International Journal of Environmental Research and Public Health. 2021; 18(16): 8638
[Pubmed]  [Google Scholar] [DOI]
36 Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?
Shani Witman Tsur, Eli Adrian Zaher, Meydan Tsur, Karolina Kania, Alicja Kalinowska-Lyszczarz
International Journal of Molecular Sciences. 2021; 22(8): 3859
[Pubmed]  [Google Scholar] [DOI]
37 COVID-19: Insights into Potential Vaccines
Ke-Yan Loo, Vengadesh Letchumanan, Hooi-Leng Ser, Siew Li Teoh, Jodi Woan-Fei Law, Loh Teng-Hern Tan, Nurul-Syakima Ab Mutalib, Kok-Gan Chan, Learn-Han Lee
Microorganisms. 2021; 9(3): 605
[Pubmed]  [Google Scholar] [DOI]
38 Development of Fish Parasite Vaccines in the OMICs Era: Progress and Opportunities
Saloni Shivam, Mansour El-Matbouli, Gokhlesh Kumar
Vaccines. 2021; 9(2): 179
[Pubmed]  [Google Scholar] [DOI]
39 Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
Lantian Lu, Viet Tram Duong, Ahmed O. Shalash, Mariusz Skwarczynski, Istvan Toth
Vaccines. 2021; 9(6): 563
[Pubmed]  [Google Scholar] [DOI]
40 Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines
Suzan Farhang-Sardroodi, Chapin S. Korosec, Samaneh Gholami, Morgan Craig, Iain R. Moyles, Mohammad Sajjad Ghaemi, Hsu Kiang Ooi, Jane M. Heffernan
Vaccines. 2021; 9(8): 861
[Pubmed]  [Google Scholar] [DOI]
41 Recombinant Antigen of Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV-2) Promotes M1 Repolarization of Porcine Alveolar Macrophages and Th1 Type Response
Rika Wahyuningtyas, Yin-Siew Lai, Mei-Li Wu, Hsin-Wei Chen, Wen-Bin Chung, Hso-Chi Chaung, Ko-Tung Chang
Vaccines. 2021; 9(9): 1009
[Pubmed]  [Google Scholar] [DOI]
42 COVID-19 Vaccine Platforms: Challenges and Safety Contemplations
Hadeel T. Al-Jighefee, Hoda Najjar, Muna Nizar Ahmed, Abeer Qush, Sara Awwad, Layla Kamareddine
Vaccines. 2021; 9(10): 1196
[Pubmed]  [Google Scholar] [DOI]
43 A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda, Shahana Sharmin, Mohd. Raeed Jamiruddin, Mainul Haque, Nihad Adnan
Vaccines. 2021; 9(12): 1387
[Pubmed]  [Google Scholar] [DOI]
44 A Review of UK-Registered and Candidate Vaccines for Bovine Respiratory Disease
Joanne L. Lemon, Michael J. McMenamy
Vaccines. 2021; 9(12): 1403
[Pubmed]  [Google Scholar] [DOI]
45 Factor Influences for Diagnosis and Vaccination of Avian Infectious Bronchitis Virus (Gammacoronavirus) in Chickens
Md. Safiul Alam Bhuiyan, Zarina Amin, Ag Muhammad Sagaf Abu Bakar, Suryani Saallah, Noor Hydayaty Md. Yusuf, Sharifudin Md. Shaarani, Shafiquzzaman Siddiquee
Veterinary Sciences. 2021; 8(3): 47
[Pubmed]  [Google Scholar] [DOI]
46 Immune responses induced by different vaccine platforms against coronavirus disease-19
Eknath D. Ahire, Sanjay J Kshirsagar
Exploration of Immunology. 2021; : 243
[Pubmed]  [Google Scholar] [DOI]
47 COVID-19 Vaccine: Critical Questions with Complicated Answers
Mohammad Faisal Haidere, Zubair Ahmed Ratan, Senjuti Nowroz, Sojib Bin Zaman, You-Jung Jung, Hassan Hosseinzadeh, Jae Youl Cho
Biomolecules & Therapeutics. 2021; 29(1): 1
[Pubmed]  [Google Scholar] [DOI]
48 Vaccine in response to COVID-19: Recent developments, challenges, and a way out
Sameer Quazi
Biomedical and Biotechnology Research Journal (BBRJ). 2021; 5(2): 105
[Pubmed]  [Google Scholar] [DOI]
49 COVID-19 vaccines: A ray of hope
Neha Chand, Rajani Mathur, Shridhar Dwivedi
Indian Journal of Medical Specialities. 2021; 12(4): 188
[Pubmed]  [Google Scholar] [DOI]
50 A comprehensive insight on the COVID-19 vaccine candidates
Anu Sharma, RaviPrakash Sharma, Rimplejeet Kaur, Ria Sharma, Surjit Singh
Journal of Family Medicine and Primary Care. 2021; 10(7): 2457
[Pubmed]  [Google Scholar] [DOI]
51 Vaccinations in patients with multiple sclerosis: review and recommendations
Cassie Nesbitt, Louise Rath, Michael Zhong, Allen C Cheng, Helmut Butzkueven, Robb Wesselingh, Olga Skibina, Mastura Monif, Wei Yeh, Julia ML Brotherton, Stephen Reddel, Anneke Van Der Walt
Medical Journal of Australia. 2021; 214(8): 350
[Pubmed]  [Google Scholar] [DOI]
52 High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice
Kirstie M. Mangas, Nicholas J. Tobias, Estelle Marion, Jérémie Babonneau, Laurent Marsollier, Jessica L. Porter, Sacha J. Pidot, Chinn Yi Wong, David C. Jackson, Brendon Y. Chua, Timothy P. Stinear
PeerJ. 2020; 8: e9659
[Pubmed]  [Google Scholar] [DOI]
53 Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseases
Lizdany Flórez-Álvarez, Lanie Ruiz-Perez, Natalia Taborda, Juan C Hernandez
Immunotherapy. 2020; 12(5): 311
[Pubmed]  [Google Scholar] [DOI]
54 Clinician's Perspective on the Use of Hepatitis A Vaccine in Indian Children
Rishi Jain, Chetan Trivedi, Sanjay Marathe, Nishchal Bhat, Archana Karadkhele, Gaurav Puppalwar
Pediatric Infectious Disease. 2020; 1(4): 148
[Pubmed]  [Google Scholar] [DOI]
55 Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases
Asha Shelly, Priya Gupta, Rahul Ahuja, Sudeepa Srichandan, Jairam Meena, Tanmay Majumdar
Viruses. 2020; 12(10): 1150
[Pubmed]  [Google Scholar] [DOI]
56 Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
Kristal M. Maner-Smith, Johannes B. Goll, Manoj Khadka, Travis L. Jensen, Jennifer K. Colucci, Casey E. Gelber, Carolyn J. Albert, Steven E. Bosinger, Jacob D. Franke, Muktha Natrajan, Nadine Rouphael, Robert A. Johnson, Patrick Sanz, Evan J. Anderson, Daniel F. Hoft, Mark J. Mulligan, David A. Ford, Eric A. Ortlund
Vaccines. 2020; 8(3): 414
[Pubmed]  [Google Scholar] [DOI]
57 Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
Andrea Chiricozzi, Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Vaccines. 2020; 8(4): 769
[Pubmed]  [Google Scholar] [DOI]
58 Vaccination in Atherosclerosis
Felix Sebastian Nettersheim, Lauren De Vore, Holger Winkels
Cells. 2020; 9(12): 2560
[Pubmed]  [Google Scholar] [DOI]
59 Narrative Review on Health-EDRM Primary Prevention Measures for Vector-Borne Diseases
Emily Chan, Tiffany Sham, Tayyab Shahzada, Caroline Dubois, Zhe Huang, Sida Liu, Kevin Hung, Shelly Tse, Kin Kwok, Pui-Hong Chung, Ryoma Kayano, Rajib Shaw
International Journal of Environmental Research and Public Health. 2020; 17(16): 5981
[Pubmed]  [Google Scholar] [DOI]
60 Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic
Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, Paola Brandi, Daniela Marasco
Frontiers in Pharmacology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
61 Antimicrobial Resistance: A Tale of Nasty Enemies and Powerful Weapons
Fabiola Vacca, Dario Cardamone, Marco Troisi, Claudia Sala, Rino Rappuoli
Frontiers for Young Minds. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
62 Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever
Deborah L. Cross, Marije K. Verheul, Michael D. Leipold, Gerlinde Obermoser, Celina Jin, Elizabeth Jones, Joshua S. Starr, Irina Mohorianu, Christoph J. Blohmke, Holden T. Maecker, Giorgio Napolitani, Jennifer Hill, Andrew J. Pollard
Frontiers in Immunology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
63 Emerging Concepts and Technologies in Vaccine Development
Morgan Brisse, Sophia M. Vrba, Natalie Kirk, Yuying Liang, Hinh Ly
Frontiers in Immunology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]

Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic

Nandeeta Samad, Temitayo Eniola Sodunke, Hasan Al Banna, Ashmita Sapkota, Aneeka Nawar Fatema, Katia Iskandar, Dilshad Jahan, Timothy Craig Hardcastle, Tanzina Nusrat, Tajkera Sultana Chowdhury, Mainul Haque
Risk Management and Healthcare Policy. 2020; Volume 13: 2707
[Pubmed]  [Google Scholar] [DOI]
65 A COVID-19 vaccine—dare to dream
Alison Phillis
British Journal of Community Nursing. 2020; 25(12): 2
[Pubmed]  [Google Scholar] [DOI]
66 COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
Shaghayegh Sadeghmousavi, Nima Rezaei
SN Comprehensive Clinical Medicine. 2020; 2(10): 1802
[Pubmed]  [Google Scholar] [DOI]
67 Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
Peter Yamoah, Thelma Mpoku Alalbila, Varsha Bangalee, Frasia Oosthuizen
Therapeutic Innovation & Regulatory Science. 2020; 54(6): 1359
[Pubmed]  [Google Scholar] [DOI]
68 Incorporation of a Novel CD4+ Helper Epitope Identified from Aquifex aeolicus Enhances Humoral Responses Induced by DNA and Protein Vaccinations
Ziyang Xu, Neethu Chokkalingam, Edgar Tello-Ruiz, Susanne Walker, Daniel W. Kulp, David B. Weiner
iScience. 2020; 23(8): 101399
[Pubmed]  [Google Scholar] [DOI]
69 COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!
Mohammad S. Khuroo, Mohammad Khuroo, Mehnaaz S. Khuroo, Ahmad A. Sofi, Naira S. Khuroo
Journal of Clinical and Experimental Hepatology. 2020; 10(6): 610
[Pubmed]  [Google Scholar] [DOI]
70 Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
Mohammad Abdallah, Olivia O. Müllertz, Ian K. Styles, Alexander Mörsdorf, John F. Quinn, Michael R. Whittaker, Natalie L. Trevaskis
Journal of Controlled Release. 2020; 327: 117
[Pubmed]  [Google Scholar] [DOI]
71 Designing the Next Generation of Vaccines: Relevance for Future Pandemics
Jorge Domínguez-Andrés, Reinout van Crevel, Maziar Divangahi, Mihai G. Netea, Vinayaka R. Prasad
mBio. 2020; 11(6)
[Pubmed]  [Google Scholar] [DOI]
72 Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications
Noah Pacifici, Amir Bolandparvaz, Jamal S. Lewis
Advanced Therapeutics. 2020; 3(11): 2000129
[Pubmed]  [Google Scholar] [DOI]
73 Effects of MS disease-modifying therapies on responses to vaccinations: A review.
John Robert Ciotti, Manouela V. Valtcheva, Anne Haney Cross
Multiple Sclerosis and Related Disorders. 2020; 45: 102439
[Pubmed]  [Google Scholar] [DOI]
74 Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
Ravikant Piyush, Keshav Rajarshi, Rajni Khan, Shashikant Ray
Open Biology. 2020; 10(9): 200174
[Pubmed]  [Google Scholar] [DOI]
75 Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer
Jenna A. Dombroski, Nidhi Jyotsana, Davis W. Crews, Zhenjiang Zhang, Michael R. King
Langmuir. 2020; 36(23): 6531
[Pubmed]  [Google Scholar] [DOI]
76 In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1
Bijara Devi Sanasam, Sanjeev Kumar
Molecular Immunology. 2019; 116: 131
[Pubmed]  [Google Scholar] [DOI]
77 Lectins as mitosis stimulating factors: Briefly reviewed
Elba V.M.M. Carvalho, Weslley F. Oliveira, Luana C.B.B. Coelho, Maria T.S. Correia
Life Sciences. 2018; 207: 152
[Pubmed]  [Google Scholar] [DOI]
78 Measuring autophagy level along with vaccine reactive IFN-?+CD4+ Th1 cells may be a promising approach to understand effi cacy of anti TB vaccine(s)
Parkash Om
Journal of Vaccines and Immunology. 2018; : 001
[Pubmed]  [Google Scholar] [DOI]
79 Effects of different cytokines on immune responses of rainbow trout in a virus DNA vaccination model
Yongsheng Cao, Qiya Zhang, Liming Xu, Shaowu Li, Di Wang, Jingzhuang Zhao, Hongbai Liu, Jian Feng, Tongyan Lu
Oncotarget. 2017; 8(68): 112222
[Pubmed]  [Google Scholar] [DOI]
80 The ongoing evolution of antibody-based treatments for Ebola virus infection
Emelissa J Mendoza, Trina Racine, Gary P Kobinger
Immunotherapy. 2017; 9(5): 435
[Pubmed]  [Google Scholar] [DOI]
81 Scrutinizing MHC-I Binding Peptides and Their Limits of Variation
Koch, C.P. and Perna, A.M. and Pillong, M. and Todoroff, N.K. and Wrede, P. and Folkers, G. and Hiss, J.A. and Schneider, G.
PLoS Computational Biology. 2013; 9(6)
[Pubmed]  [Google Scholar]
82 Immunization update: A 2011 retrospective on product changes and new recommendations
Phillips, K. and Alves, V.
Formulary. 2012; 47(2): 58-74
[Pubmed]  [Google Scholar]


Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008